(Q36410579)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16510037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

HBV plus HCV, HCV plus HIV, HBV plus HIV (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16510037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16510037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Neeraj Saraf

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16510037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Douglas T Dieterich

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16510037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 February 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16510037%20AND%20SRC:MED&resulttype=core&format=json

Current gastroenterology reports

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16510037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16510037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16510037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

67-74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16510037%20AND%20SRC:MED&resulttype=core&format=json

The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state

17 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11894-006-0066-9

Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index

21 January 2018

1 reference

12 December 2020

Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study.

1 reference

12 December 2020

Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients

1 reference

12 December 2020

Care of patients with hepatitis C and HIV co-infection

1 reference

12 December 2020

Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individuals

1 reference

12 December 2020

Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus

1 reference

12 December 2020

Dominant replication of either virus in dual infection with hepatitis viruses B and C.

1 reference

12 December 2020

Suppression of hepatitis C virus by hepatitis B virus in coinfected patients at the National University Hospital of Singapore

1 reference

12 December 2020

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

1 reference

12 December 2020

Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects

1 reference

12 December 2020

Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome

1 reference

12 December 2020

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

1 reference

12 December 2020

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine

1 reference

12 December 2020

Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus

1 reference

12 December 2020

Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients infected with HIV in an area where HBV infection is hyperendemic

1 reference

12 December 2020

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients.

1 reference

12 December 2020

Treatment of chronic hepatitis C in HIV/HCV-coinfection with interferon alpha-2b+ full-course vs. 16-week delayed ribavirin

1 reference

12 December 2020

Co-infection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver

1 reference

12 December 2020

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

1 reference

12 December 2020

Immune responses in hepatitis B virus infection

1 reference

12 December 2020

High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial

1 reference

12 December 2020

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States

1 reference

12 December 2020

Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial

1 reference

12 December 2020

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

1 reference

12 December 2020

High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV.

1 reference

12 December 2020

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase

1 reference

12 December 2020

Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection

1 reference

12 December 2020

Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infection.

1 reference

12 December 2020

Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group

1 reference

12 December 2020

Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel

1 reference

12 December 2020

Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA.

1 reference

12 December 2020

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

1 reference

12 December 2020

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

1 reference

12 December 2020

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

1 reference

12 December 2020

The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection

1 reference

12 December 2020

National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002.

1 reference

12 December 2020

The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks

1 reference

12 December 2020

Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection

1 reference

12 December 2020

HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).

1 reference

12 December 2020

Hematologic disorders associated with hepatitis C virus infection and their management

1 reference

12 December 2020

Influence of chronic coinfection with hepatitis B and C virus on liver histology.

1 reference

12 December 2020

Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine

1 reference

12 December 2020

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

1 reference

12 December 2020

Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed.

1 reference

12 December 2020

Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro

1 reference

12 December 2020

Mitochondrial toxic effects and ribavirin

1 reference

12 December 2020

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

1 reference

12 December 2020

Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine.

1 reference

12 December 2020

HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease

1 reference

12 December 2020

Fanconi-like syndrome and rhabdomyolysis in a person with HIV infection on highly active antiretroviral treatment including tenofovir

1 reference

12 December 2020

Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment.

1 reference

12 December 2020

Hepatic inflammation, hepatitis B replication, and cellular immune function in homosexual males with chronic hepatitis B and antibody to human immunodeficiency virus

1 reference

12 December 2020

Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study

1 reference

12 December 2020

Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine

1 reference

12 December 2020

Cellular immune responses in patients with dual infection of hepatitis B and C viruses: dominant role of hepatitis C virus

1 reference

12 December 2020

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease

1 reference

12 December 2020

Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.

1 reference

12 December 2020

Proximal tubular kidney damage and tenofovir: a role for mitochondrial toxicity?

1 reference

12 December 2020

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

1 reference

12 December 2020

10.1007/S11894-006-0066-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16510037%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference